Original paper
Performance of Xpert MTB/RIF Ultra: a matter of dead or alive
Abstract
In our opinion, the implementation of the Xpert MTB/RIF assay (Cepheid, Sunnyvale, CA, USA) since 2010 has revolutionised molecular diagnosis of (multidrug-resistant) tuberculosis. Xpert combines early diagnosis of tuberculosis with direct detection of rifampicin resistance, but the limitations of the assay are its suboptimal sensitivity and high rate of false positivity in low-prevalence settings. To overcome these limitations, the assay was...
Paper Details
Title
Performance of Xpert MTB/RIF Ultra: a matter of dead or alive
Published Date
Dec 5, 2017
Volume
18
Issue
1
Pages
8 - 10